Howard Hughes Medical Institute’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Howard Hughes Medical Institute’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,894	Closed	-$500K	–	189
2015 Q1	$500K	Buy	2,894 +145	+5%	+$21.3K	0.07%	98
2014 Q4	$316K	Buy	2,749 +556	+25%	+$67.4K	0.08%	115
2014 Q3	$343K	Buy	2,193 +1,622	+284%	+$235K	0.08%	96
2014 Q2	$70K	Buy	+571	New	+$63.1K	0.01%	136

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Howard Hughes Medical Institute's SLXP Position: Q2 2015 in Review

Howard Hughes Medical Institute sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,894 shares — an estimated $500K sold.

Howard Hughes Medical Institute first reported a position in SLXP in Q2 2014 and held it in 4 quarters. The position peaked at $500K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Howard Hughes Medical Institute reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Howard Hughes Medical Institute sold 2,894 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $500K.
Howard Hughes Medical Institute first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 4 quarters.
Howard Hughes Medical Institute's SALIX PHARMACEUTICALS LTD DEL position peaked at $500K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2015, filed 13 Aug 2015.